Frequently Asked Questions

IS THE EMAIL I RECEIVED A LEGITIMATE FEASIBILITY REQUEST?

Yes, Ryght is an established technology service provider. 

The email you received is from a legitimate pharmaceutical sponsor or CRO who is using our platform to conduct their feasibility assessment. We never send unsolicited emails - you were specifically selected because your site matches the requirements for a real clinical trial opportunity.

We do not ask for passwords, credit card information, or sensitive personal data. The questionnaire is strictly focused on your site’s clinical capabilities (e.g., patient volume, equipment, and staff experience).

WHY HAVEN'T I HEARD OF RYGHT AI BEFORE?

Ryght AI was founded in 2023 and has been growing rapidly since then. While we may be newer than some traditional clinical trial technology companies, we're backed by major industry players (Accenture, Microsoft, NVIDIA) and work with established CROs like Biorasi and QPS Holdings. Our platform is already used by leading pharmaceutical sponsors and trusted by major academic medical centers including USC, Mayo Clinic, and the Medical College of Wisconsin.

HOW DID YOU GET MY CONTACT INFORMATION?

Your site information comes from publicly available data sources, including clinical trial databases, institutional websites, and our network of 100,000+ clinical research sites. When sponsors use our platform, they select sites based on specific criteria such as therapeutic expertise, patient populations, and historical trial performance. Your site was identified as a strong potential match for their study requirements.

IS THERE ANY COST TO COMPLETE THE FEASIBILITY QUESTIONNAIRE?

No, absolutely not. Completing the feasibility questionnaire is completely free for research sites. Our platform is paid for by the pharmaceutical sponsors and CROs who are seeking qualified sites for their trials. Research sites can access and use our feasibility tools at no cost.

If you create an account with us, you can see 

WHO SEES THE INFORMATION THAT I SUBMIT?

The information you provide in the questionnaire is delivered directly to the Clinical Operations or Study Team at the sponsoring company listed in your email. It is used to determine if the study is a good fit for your research site's capabilities.  

WHAT HAPPENS TO MY DATA? 

Data security is our top priority. Ryght AI is SOC 2 Type 2 compliant, which means we meet rigorous security standards used by Fortune 500 companies. Your feasibility responses are only shared with the specific sponsor or CRO who sent the request. We use enterprise-grade encryption, maintain HIPAA-aligned practices, and never sell or share your data with unauthorized parties.

WHAT IF I DON'T WANT TO BE CONSIDERED FOR THE STUDY?

That's completely fine. Completing the questionnaire doesn't commit you to anything. It firstly informs the sponsor whether or not you would like to be considered, and secondly if your site is a good fit. You can decline to participate by responding "no" to the question "Are you interested in participating in this study?"

If you'd prefer not to receive future feasibility requests, please let us know through the contact form below.

WHAT HAPPENS AFTER I SUBMIT THE QUESTIONNAIRE?

Once submitted, the Sponsor will review your responses. If your site meets the initial requirements for the study, a representative from the Sponsor or their CRO will contact you directly regarding the next steps, such as a Site Selection Visit (SSV).

WHO DO I CONTACT WITH QUESTIONS ABOUT THE STUDY OR QUESTIONNAIRE? 

The email you received should include a protocol synopsis for the study that should contain all the information you need to know about the study. If you still have questions about the protocol, or about the questionnaire, please use the contact form on this page or email support@ryght.ai.